Prometheus Labs

Prometheus Laboratories is a commercial-stage, private diagnostics company with a deep focus on GI diseases, particularly Inflammatory Bowel Disease (IBD). It has built an industry-leading portfolio of proprietary tests that provide actionable data across the entire patient care continuum, performing over one million tests annually. The company leverages its scientific expertise in immunology and drug metabolism to offer precision-guided solutions for therapy selection, dosing optimization (PredictrPK), and therapeutic drug monitoring (Anser series). Its recent launch of IBD Precis™ and expansion of its dosing tests demonstrate a commitment to innovation within its core market.

Specialized clinical laboratory integrating biomarker discovery (serology, genetics, enzymology) with therapeutic drug monitoring (TDM) and pharmacokinetic/pharmacodynamic (PK/PD) modeling to create precision-guided diagnostic solutions for GI diseases.

Prometheus competes in the GI diagnostics space with large national clinical laboratories (Labcorp, Quest Diagnostics), other specialty labs focusing on immunology and TDM (e.g., Exagen), and in-house hospital laboratories. Its competitive edge is its deep, specialized focus on IBD, offering an integrated suite of tests covering the entire patient journey, which is less common among larger, generalized competitors.